Investing.com - argenx ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
argenx ADR announced earnings per share of $1.17 on revenue of $470.4M. Analysts polled by Investing.com anticipated EPS of $-3.29 on revenue of $48.94M.
argenx ADR shares are down 1.83% from the beginning of the year, still down 19.53% from its 52 week high of $382.15 set on February 11. They are under-performing the Nasdaq which is up 14.54% from the start of the year.
argenx ADR follows other major Healthcare sector earnings this month
argenx ADR's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar